{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:11:41Z","timestamp":1790316701326,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02364851"],"award-info":[{"award-number":["GR-2016-02364851"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2011-02351840"],"award-info":[{"award-number":["RF-2011-02351840"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["RFA187G14"],"award-info":[{"award-number":["RFA187G14"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["RFA218G18"],"award-info":[{"award-number":["RFA218G18"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cellsig.2019.109495","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T12:35:41Z","timestamp":1575635741000},"page":"109495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Metabolic reprogramming and the role of mitochondria in polycystic kidney disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Christine","family":"Podrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4704-4006","authenticated-orcid":false,"given":"Alessandra","family":"Boletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2019.109495_bb0005","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cellsig.2019.109495_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cellsig.2019.109495_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-018-0200-x","article-title":"Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways","volume":"1","author":"Podrini","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2019.109495_bb0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2019.109495_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cas.12085","article-title":"Cancer metabolism: key players in metabolic reprogramming","volume":"104","author":"Soga","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cellsig.2019.109495_bb0045","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146654","article-title":"Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney disease","volume":"11","author":"Riwanto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2019.109495_bb0055","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1096\/fj.201700909R","article-title":"Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD)","volume":"32","author":"Nikonova","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.cellsig.2019.109495_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease","volume":"176","author":"Lian","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40620-017-0395-9","article-title":"Defective glycolysis and the use of 2-deoxy-D-glucose in polycystic kidney disease: from animal models to humans","volume":"30","author":"Magistroni","year":"2017","journal-title":"J Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0075","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1681\/ASN.2015101113","article-title":"Slowing polycystic kidney disease by fasting","volume":"27","author":"Boletta","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0080","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.cellsig.2019.109495_bb0085","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2019.109495_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","article-title":"Defining the role of mTOR in cancer","volume":"12","author":"Guertin","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"Duvel","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nm.3140","article-title":"Metabolic reprogramming in polycystic kidney disease","volume":"19","author":"Priolo","year":"2013","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellsig.2019.109495_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.cellsig.2019.109495_bb0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cmet.2018.07.020","article-title":"Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo","volume":"28","author":"Courtney","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.cellsig.2019.109495_bb0115","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cellsig.2019.109495_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s42255-019-0032-0","article-title":"Metabolic signatures of cancer cells and stem cells","volume":"1","author":"Intlekofer","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.cellsig.2019.109495_bb0130","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cellsig.2019.109495_bb0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0140","doi-asserted-by":"crossref","first-page":"F492","DOI":"10.1152\/ajprenal.00238.2015","article-title":"The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate","volume":"309","author":"Hwang","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03036-y","article-title":"Lkb1 deficiency confers glutamine dependency in polycystic kidney disease","volume":"9","author":"Flowers","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.cellsig.2019.109495_bb0150","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ndt\/gfx349","article-title":"Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease","volume":"33","author":"Soomro","year":"2018","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.cellsig.2019.109495_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3233\/KCA-180043","article-title":"The \u2018Achilles Heel\u2019 of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy","volume":"3","author":"Hoerner","year":"2019","journal-title":"Kidney Cancer"},{"key":"10.1016\/j.cellsig.2019.109495_bb0160","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: Function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cellsig.2019.109495_bb0165","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cellsig.2019.109495_bb0170","doi-asserted-by":"crossref","first-page":"F1855","DOI":"10.1152\/ajprenal.00025.2018","article-title":"Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis","volume":"315","author":"Trott","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier","volume":"8","author":"Menezes","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0180","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/jn\/130.9.2356","article-title":"High dietary fat intake increases renal cyst disease progression in Han:SPRD-cy rats","volume":"130","author":"Jayapalan","year":"2000","journal-title":"J Nutr"},{"key":"10.1016\/j.cellsig.2019.109495_bb0185","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jn\/133.1.180","article-title":"Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats","volume":"133","author":"Lu","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.cellsig.2019.109495_bb0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.cellsig.2019.109495_bb0195","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14395","article-title":"microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cellsig.2019.109495_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11918-y","article-title":"Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease","volume":"10","author":"Lee","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cellsig.2019.109495_bb0205","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41598-019-38566-y","article-title":"Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth","volume":"9","author":"Yheskel","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cellsig.2019.109495_bb0210","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.15252\/embj.201796438","article-title":"MYC and tumor metabolism: chicken and egg","volume":"36","author":"Dejure","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.cellsig.2019.109495_bb0215","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","article-title":"Malonyl-CoA: the regulator of fatty acid synthesis and oxidation","volume":"122","author":"Foster","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cellsig.2019.109495_bb0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00467-016-3556-5","article-title":"Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities","volume":"32","author":"Hackl","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0225","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2019.109495_bb0230","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2007.04.035","article-title":"HEF1-dependent Aurora A activation induces disassembly of the primary cilium","volume":"129","author":"Pugacheva","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0235","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00186.2017","article-title":"An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease","volume":"313","author":"Yanda","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.cdd.4401231","article-title":"Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis","volume":"10","author":"Gottlieb","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.cellsig.2019.109495_bb0245","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm3412","article-title":"Mitochondria as sensors and regulators of calcium signalling","volume":"13","author":"Rizzuto","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1091\/mbc.e16-08-0597","article-title":"The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function","volume":"28","author":"Padovano","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0255","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00337-17","article-title":"Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease","volume":"37","author":"Ishimoto","year":"2017","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0260","doi-asserted-by":"crossref","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","article-title":"PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice","volume":"314","author":"Lakhia","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0265","article-title":"A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.cellsig.2019.109495_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7397","article-title":"Polycystin 2 regulates mitochondrial Ca(2+) signaling, bioenergetics, and dynamics through mitofusin 2","volume":"12","author":"Kuo","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.cellsig.2019.109495_bb0275","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.280.5370.1763","article-title":"Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses","volume":"280","author":"Rizzuto","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2019.109495_bb0280","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbamcr.2018.10.016","article-title":"Calcium, mitochondria and cell metabolism: A functional triangle in bioenergetics","volume":"1866","author":"Rossi","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.cellsig.2019.109495_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005651","article-title":"The mitochondrial transporter SLC25A25 links ciliary TRPP2 signaling and cellular metabolism","volume":"16","author":"Hofherr","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0290","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI21753","article-title":"Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus","volume":"114","author":"Chauvet","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cellsig.2019.109495_bb0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0300","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccr.2007.02.005","article-title":"Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway","volume":"11","author":"Pollard","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0305","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/2159-8290.CD-13-0696","article-title":"L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer","volume":"4","author":"Shim","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.cellsig.2019.109495_bb0310","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","article-title":"Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling","volume":"20","author":"Adam","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0315","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","article-title":"SDH mutations in cancer","volume":"1807","author":"Bardella","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cellsig.2019.109495_bb0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s10038-018-0530-z","article-title":"Carnitine palmitoyltransferase II deficiency with a focus on newborn screening","volume":"64","author":"Tajima","year":"2019","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0325","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgme.2008.05.002","article-title":"CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency","volume":"94","author":"Isackson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cellsig.2019.109495_bb0330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00442081","article-title":"Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings","volume":"139","author":"Lehnert","year":"1982","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.cellsig.2019.109495_bb0335","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrneurol.2013.126","article-title":"The clinical maze of mitochondrial neurology","volume":"9","author":"DiMauro","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/82826","article-title":"Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes","volume":"26","author":"Inoue","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0345","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/90976","article-title":"Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA","volume":"7","author":"Nakada","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.cellsig.2019.109495_bb0350","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbrc.2005.05.155","article-title":"Application of ES cells for generation of respiration-deficient mice carrying mtDNA with a large-scale deletion","volume":"333","author":"Ishikawa","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cellsig.2019.109495_bb0355","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2019.109495_bb0360","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1538\/expanim.18-0060","article-title":"Mito-mice and mitochondrial DNA mutator mice as models of human osteoporosis caused not by aging but by hyperparathyroidism","volume":"67","author":"Mito","year":"2018","journal-title":"Exp Anim"},{"key":"10.1016\/j.cellsig.2019.109495_bb0365","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia","volume":"17","author":"Patel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cellsig.2019.109495_bb0370","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cellsig.2019.109495_bb0375","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1681\/ASN.2014090875","article-title":"Combined deletion of Vhl and Kif3a accelerates renal cyst formation","volume":"26","author":"Lehmann","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031034","article-title":"Renal tubular HIF-2alpha expression requires VHL inactivation and causes fibrosis and cysts","volume":"7","author":"Schietke","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2019.109495_bb0385","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1824-7288-35-37","article-title":"Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy","volume":"35","author":"Distefano","year":"2009","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.cellsig.2019.109495_bb0395","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply","volume":"38","author":"Choo","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0400","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cell.2013.04.023","article-title":"The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4","volume":"153","author":"Csibi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0405","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0410","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","article-title":"Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk\/cpk) mouse","volume":"35","author":"Deshmukh","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cellsig.2019.109495_bb0415","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cellsig.2019.109495_bb0420","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ckj\/sfy103","article-title":"Management of autosomal-dominant polycystic kidney disease-state-of-the-art","volume":"11","author":"Muller","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.cellsig.2019.109495_bb0425","first-page":"219","article-title":"Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression","volume":"152","author":"Trudel","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0430","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.315127.118","article-title":"A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease","volume":"32","author":"Cai","year":"2018","journal-title":"Genes Dev"},{"key":"10.1016\/j.cellsig.2019.109495_bb0435","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cellsig.2019.109495_bb0440","article-title":"Metformin inhibits cyst formation in a zebrafish model of polycystin-2 deficiency","volume":"7","author":"Chang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cellsig.2019.109495_bb0445","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000488807","article-title":"A randomized clinical trial of metformin to treat autosomal dominant polycystic kidney disease","volume":"47","author":"Seliger","year":"2018","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0450","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2019.109495_bb0455","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cellsig.2019.109495_bb0460","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1083\/jcb.201511036","article-title":"Metabolic regulation of mitochondrial dynamics","volume":"212","author":"Mishra","year":"2016","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53061-0","article-title":"Polycystin-1 regulates actomyosin contraction and the cellular response to extracellular stiffness","volume":"9","author":"Nigro","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.cellsig.2019.109495_bb0470","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting metabolism for cancer therapy","volume":"24","author":"Luengo","year":"2017","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0475","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1681\/ASN.2013101122","article-title":"Polycystic kidney disease and cancer after renal transplantation","volume":"25","author":"Wetmore","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0480","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/j.cellsig.2019.109495_bb0485","doi-asserted-by":"crossref","first-page":"R378","DOI":"10.1016\/S0960-9822(02)00877-1","article-title":"Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease","volume":"12","author":"Pazour","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0490","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia","volume":"13","author":"Yoder","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cellsig.2019.109495_bb0495","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat Genet"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656819302918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656819302918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:23:13Z","timestamp":1777580593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656819302918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":99,"alternative-id":["S0898656819302918"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2019.109495","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2019.109495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109495"}}